Back to Browse Journals » Open Access Journal of Contraception » Volume 5

Communicating sexual health messages: young adults and the female condom

Authors Markham Shaw C, Chatterjee K

Published Date June 2014 Volume 2014:5 Pages 29—37

DOI http://dx.doi.org/10.2147/OAJC.S64160

Received 16 March 2014, Accepted 16 April 2014, Published 30 June 2014

Charla Markham Shaw, Karishma Chatterjee

Department of Communication, University of Texas at Arlington, Arlington, Texas, USA

Purpose: This study examined how young adult college men and women (18 to 24 years of age) viewed the female condom, in terms of its viability as a technology to be used for protection against sexually transmitted infections (STIs) and unplanned pregnancies.
Patients and methods: Information sessions led by same-sex peer educators were conducted with 55 male and 94 female participants in same-sex, small groups, followed by completion of anonymous online surveys, during Spring 2013, at a large public university in the southwestern United States.
Results: Using a grounded theory approach, the core characteristics of the FC2® female condom found to be important to the female participants were its design, lack of side effects, protection, and convenience; the male participants focused on the protection and design elements.
Conclusion: Message-design implications for health promotion initiatives and practical implications for health practitioners were discussed.

Keywords: diffusion of innovation, STI prevention, pregnancy prevention, contraception

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Clinical utility of pharmacogenomics in the management of hepatitis C

Trinks J, Hulaniuk ML, Redal MA, Flichman D

Pharmacogenomics and Personalized Medicine 2014, 7:339-347

Published Date: 20 October 2014

Causal diagrams and the logic of matched case-control studies [Corrigendum]

Shahar E, Shahar DJ

Clinical Epidemiology 2014, 6:59-60

Published Date: 22 January 2014

Current and future biosimilars: potential practical applications in rheumatology

Noaiseh G, Moreland L

Biosimilars 2013, 3:27-33

Published Date: 1 August 2013

BAK additive influence on results

Shah RD, Lemon TI, Yarrow-Jenkins A

Clinical Ophthalmology 2013, 7:1081-1082

Published Date: 6 June 2013

Corrigendum

Mizoguchi T, Ozaki M, Unoki K, Dake Y, Eto T, Arai M

Clinical Ophthalmology 2012, 6:1717-1718

Published Date: 26 October 2012

Do calcifying nanoparticles really contain 16S rDNA?

Shiekh FA

International Journal of Nanomedicine 2012, 7:5051-5052

Published Date: 18 September 2012

Matched case-control studies: a review of reported statistical methodology

Niven DJ, Berthiaume LR, Fick GH, Laupland KB

Clinical Epidemiology 2012, 4:99-110

Published Date: 27 April 2012

Influence of demographic and metabolic variables on forearm blood flow and vascular conductance in individuals without overt heart disease

Thiago E Sartori, Rafael AB Nunes, Gisela T da Silva, et al

Vascular Health and Risk Management 2010, 6:431-437

Published Date: 31 May 2010